Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 663 results for diabetes

  1. Diabetes: annual care processes (IND10)

    This indicator covers the proportion of adults with diabetes who have received all 9 basic care processes. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG13

  2. Diabetes: offered retinal screening (IND69)

    This indicator covers the proportion of eligible people with diabetes who are offered an appointment for diabetic eye screening. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG88

  3. Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes [ID6259]

    In development Reference number: GID-TA10981 Expected publication date:  08 April 2026

  4. Type 2 diabetes: insulin degludec (ESNM25)

    Summary of the evidence on insulin degludec for treating type 2 diabetes to inform local NHS planning and decision-making

  5. Diabetes: annual BMI (children T2DM) (IND301)

    This indicator covers the proportion of children and young people aged under 18 years with type 2 diabetes who have had their BMI recorded in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  6. Diabetes: annual BMI (children T1DM) (IND300)

    This indicator covers the proportion of children and young people aged under 18 years with type 1 diabetes who have had their BMI recorded in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  7. Diabetes: annual HbA1c (children T2DM) (IND299)

    This indicator covers the proportion of children and young people aged under 18 years with type 2 diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  8. Diabetes: annual HbA1c (children T1DM) (IND298)

    This indicator covers the proportion of children and young people aged under 18 years with type 1 diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  9. Diabetes: excluded from retinal screening (IND71)

    This indicator covers the proportion of eligible people with diabetes who are excluded from diabetic eye screening as they have opted out or are classed as medically unfit. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG90

  10. Diabetes: suspended from retinal screening (IND70)

    This indicator covers the proportion of eligible people with diabetes who are suspended from diabetic eye screening due to previous screening results. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG89

  11. Diabetes: did not attend retinal screening (IND68)

    This indicator covers the proportion of eligible people with diabetes who have not attended for diabetic eye screening in the previous 3 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG87

  12. Orforglipron for treating type 2 diabetes [TSID12130]

    Topic prioritisation

  13. Diabetes: admission rates (renal replacement therapy) (IND45)

    This indicator covers admission rates for renal replacement therapy in people with diabetes. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG63

  14. Diabetes: annual blood pressure (children T2DM) (IND303)

    This indicator covers the proportion of children and young people aged under 18 years with type 2 diabetes who have had their blood pressure recorded in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  15. Diabetes: annual blood pressure (children T1DM) (IND302)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 1 diabetes who have had their blood pressure recorded in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes